Microdosing GLP-1 medications is largely experimental and lacks scientific support from clinical trials
By prioritizing protein intake, resistance training, and maintaining an active lifestyle , individuals can mitigate muscle deterioration while still reaping the benefits of these medications
Rx semaglutide Ozempic (semaglutide) is a GLP-1 injection to support weight loss for individuals with type 2 diabetes
Retatrutide, scientifically known as LY3437943 , is a novel peptide designed for therapeutic applications
Frequently Asked Questions As of July 2026, retatrutide has completed four Phase 3 readouts: TRIUMPH-4 (28.7% weight loss in knee OA population, December 2025), TRIUMPH-1 (28.3% weight loss in 2,339 general obesity patients, May 2026), TRANSCEND-T2D-1 (-2.0% HbA1c and 16.8% weight loss in 537 T2D patients, June 2026), and the TRIUMPH-1 sleep apnea substudy (60.6% AHI reduction, June 2026)
For instance, Wegovy s safety and efficacy were studied in four 68-week trials